Trade DRTSW stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Alpha Tau Medical Ltd. Warrant (DRTSW) is trading at US$4.00, up 4.44% today as of Sep 10, 16:00 EDT. Over the past 52 weeks, DRTSW has traded between US$0.20 and US$4.29. On Syfe you can trade DRTSW with $0 commission and add it to your watchlist.
| Previous close | US$3.83 |
|---|---|
| 52-week range | US$0.20 – US$4.29 |
| Volume | 45.8K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Alpha Tau Medical Ltd. Warrant
Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.
Year: 2022
Alpha Tau Medical Ltd. Warrant (DRTSW) stock is trading at US$4.00, +4.44% from the previous close of US$3.83.
The 52-week high for Alpha Tau Medical Ltd. Warrant (DRTSW) stock is US$4.29.
The 52-week low for Alpha Tau Medical Ltd. Warrant (DRTSW) stock is US$0.20.
Alpha Tau Medical Ltd. Warrant (DRTSW) does not currently pay a dividend.
Stay on top of DRTSW
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
